Machine Learning in Drug Metabolism Study

被引:3
|
作者
Sinha, Krishnendu [1 ]
Ghosh, Jyotirmoy [2 ]
Sil, Parames Chandra [3 ,4 ]
机构
[1] Jhargram Raj Coll, Dept Zool, Jhargram 721507, India
[2] Banwarilal Bhalotia Coll, Dept Chem, Asansol 713303, India
[3] Bose Inst, Dept Div Mol Med, Kolkata 700054, India
[4] Bose Inst, Div Mol Med, Kolkata 700054, India
关键词
Machine learning; algorithms; deep learning; drug metabolism; metabolites; molecular docking; PHASE-I; PREDICTION; FUTURE; MECHANISMS; DISCOVERY; TOXICITY; NETWORK; MODELS; WEB;
D O I
10.2174/1389200224666221227094144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic reactions in the body transform the administered drug into metabolites. These metabolites exhibit diverse biological activities. Drug metabolism is the major underlying cause of drug overdose-related toxicity, adversative drug effects and the drug's reduced efficacy. Though metabolic reactions deactivate a drug, drug metabolites are often considered pivotal agents for off-target effects or toxicity. On the other side, in combination drug therapy, one drug may influence another drug's metabolism and clearance and is thus considered one of the primary causes of drug-drug interactions. Today with the advancement of machine learning, the metabolic fate of a drug candidate can be comprehensively studied throughout the drug development procedure. Naive Bayes, Logistic Regression, k-Nearest Neighbours, Decision Trees, different Boosting and Ensemble methods, Support Vector Machines and Artificial Neural Network boosted Deep Learning are some machine learning algorithms which are being extensively used in such studies. Such tools are covering several attributes of drug metabolism, with an emphasis on the prediction of drug-drug interactions, drug-target-interactions, clinical drug responses, metabolite predictions, sites of metabolism, etc. These reports are crucial for evaluating metabolic stability and predicting prospective drug-drug interactions, and can help pharmaceutical companies accelerate the drug development process in a less resource-demanding manner than what in vitro studies offer. It could also help medical practitioners to use combinatorial drug therapy in a more resourceful manner. Also, with the help of the enormous growth of deep learning, traditional fields of computational drug development like molecular interaction fields, molecular docking, quantitative structure-to-activity relationship (QSAR) studies and quantum mechanical simulations are producing results which were unimaginable couple of years back. This review provides a glimpse of a few contextually relevant machine learning algorithms and then focuses on their outcomes in different studies.
引用
收藏
页码:1012 / 1026
页数:15
相关论文
共 50 条
  • [11] Machine learning methods, databases and tools for drug combination prediction
    Wu, Lianlian
    Wen, Yuqi
    Leng, Dongjin
    Zhang, Qinglong
    Dai, Chong
    Wang, Zhongming
    Liu, Ziqi
    Yan, Bowei
    Zhang, Yixin
    Wang, Jing
    He, Song
    Bo, Xiaochen
    BRIEFINGS IN BIOINFORMATICS, 2022, 23 (01)
  • [12] Drug Design: The Machine Learning Roles
    EI-Telbany, Mohammed E.
    Rafat, Samah
    Nasr, Engy Ebrahim
    2014 INTERNATIONAL CONFERENCE ON ENGINEERING AND TECHNOLOGY (ICET), 2014,
  • [13] Machine Learning and Deep Learning Strategies in Drug Repositioning
    Wang, Fei
    Ding, Yulian
    Lei, Xiujuan
    Liao, Bo
    Wu, Fang-Xiang
    CURRENT BIOINFORMATICS, 2022, 17 (03) : 217 - 237
  • [14] Trends and Potential of Machine Learning and Deep Learning in Drug Study at Single-Cell Level
    Qi, Ren
    Zou, Quan
    RESEARCH, 2023, 6
  • [15] Machine Learning Techniques Applied to the Study of Drug Transporters
    Kong, Xiaorui
    Lin, Kexin
    Wu, Gaolei
    Tao, Xufeng
    Zhai, Xiaohan
    Lv, Linlin
    Dong, Deshi
    Zhu, Yanna
    Yang, Shilei
    MOLECULES, 2023, 28 (16):
  • [16] Artificial intelligence to deep learning: machine intelligence approach for drug discovery
    Gupta, Rohan
    Srivastava, Devesh
    Sahu, Mehar
    Tiwari, Swati
    Ambasta, Rashmi K.
    Kumar, Pravir
    MOLECULAR DIVERSITY, 2021, 25 (03) : 1315 - 1360
  • [17] Synergistic drug combinations and machine learning for drug repurposing in chordoma
    Anderson, Edward
    Havener, Tammy M.
    Zorn, Kimberley M.
    Foil, Daniel H.
    Lane, Thomas R.
    Capuzzi, Stephen J.
    Morris, Dave
    Hickey, Anthony J.
    Drewry, David H.
    Ekins, Sean
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [18] Unveiling drug-induced osteotoxicity: A machine learning approach and webserver
    Cui, Huizi
    He, Yi
    Wang, Zhibang
    Liu, Kaifeng
    Li, Wannan
    Han, Weiwei
    JOURNAL OF HAZARDOUS MATERIALS, 2025, 492
  • [19] Machine Learning Enables Accurate Prediction of Quinone Formation during Drug Metabolism
    Sandhu, Hardeep
    Garg, Prabha
    CHEMICAL RESEARCH IN TOXICOLOGY, 2023, 36 (12) : 1876 - 1890
  • [20] In Silico Machine Learning Methods in Drug Development
    Dobchev, Dimitar A.
    Pillai, Girinath G.
    Karelson, Mati
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (16) : 1913 - 1922